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a  b  s  t  r  a  c  t
An  emerging  literature  suggests  that  early  life  exposure  to 4-nonylphenol  (4-NP),  a widespread  endocrine
disrupting  chemical,  may  increase  the risk of  metabolic  syndrome.  In  this  study,  we  investigated  the
hypothesis  that  intraperitoneal  administration  of  4-NP  induces  hepatic  steatosis  in  rat.  24  male  Sprague-
Dawley  rats  were  administered  with  4-NP  (0, 2, 10  and  50 mg/kg  b.wt)  in  corn  oil for  30  days.  Liver
histology,  biochemical  analysis  and  gene  expression  proﬁling  were  examined.  After  treatment,  abnormal
liver  morphology  and function  were  observed  in  the  4-NP-treated  rat, and  signiﬁcant  changes  in gene
expression  an  indicator  of hepatic  steatosis  and  apoptosis  were  observed  compared  with  controls.  Up-
regulated  genes  involved  in apoptosis,  hepatotoxity  and  oxidative  stress,  increased  ROS  and  decrease  of
antioxidant  enzyme  were  observed  in the  4-NP  exposed  rat. Extensive  fatty  accumulation  in liver  sec-
tion and elevated  serum  GOT,  GPT,  LDH  and  -GT were  also  observed.  Incidence  and  severity  of  liver
steatosis  was scored  and taken  into  consideration  (steatosis,  ballooning  and lobular  inﬂammation).  Hep-
atocytes  apoptosis  could  promote  NAFLD  progression;  Fas/FasL,  TNF-  and  Caspase-9  mRNA  activation
were  important  contributing  factors  to hepatic  steatosis.  These  ﬁndings  provide  the  ﬁrst  evidence  that
4-NP affects  the  gene  expression  related  to liver  hepatotoxicity,  which  is  correlated  with  hepatic  steatosis.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).eywords:
-Nonylphenol
epatic steatosis
xidative stress
enes
iver
poptosis
Abbreviations: APNEIs, alkylphenol polyethoxylates; 4-NP, 4-nonylphenol; FAO, fatty 
olic  fatty liver disease; NASH, non-alcoholic hepatic steatosis; OS, oxidative stress; GOT
amma  glutamyltransferase; LDH, lactate dehydrogenase; AhR, aril hydrocarbon receptor
atty  acid; HSC, hepatic stellate cell; IR, insulin resistance.
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. Introduction
4-Nonylphenol (4-NP) is the ﬁnal product of alkylphenol
olyethoxylates (APNEIs), which is widely used in the prepara-
ion of lubricating oil additives, resins, plasticizers, surface-active
gents, detergents, paints, cosmetics and can be found in almost
ll environmental water matrices [19]. 4-NP is persistent and more
table than Nonylphenol polyetholate (NPE) [41]. Its ability to accu-
ulate in the organs of aquatic species is considered a potential
azard for humans and animals exposed within the food chain. This
revalent situation increases the risk of exposure for men  who  live
n urban areas and have a ﬁsh based diet (probably from contami-
ated waters) [24].
To date, studies based on NP compounds toxicity focused mainly
n estrogenic effects and related alteration to development of
eproductive system in mammalian models (e.g., rat, mouse), and
n aquatic organisms (e.g., ﬁsh, crustaceans) [42]. Hepatic tissue
mpairment was observed in different species exposed to NP [57].
n any event, the liver was proved the major organ of accumulation,
iotransformation and degradation of environmental pollutants
uch as 4-NP [32,10]. Speciﬁc estrogen receptor exists in the liver,
nd cellular response involving estrogen interactions have been
dentiﬁed. In rat, NP is extensively glucuronidated by liver micro-
omes and the glucuronidation is mediated by UGT2B1, an isoform
f UDP-glucuronosyltransferase [59,12] a rainbow trout liver after
njection [49]. After glucuronidation, the resultant glucuronide is
xcreted mainly into the bile in rats. The major metabolites con-
ugate are NP-glucuronide and p-nonylcatechol glucuronide, these
ere detected in the rat liver and serum after oral administration
12]. Moreover, evaluation of blood biochemistry was considered
 useful tool for the diagnosis of liver diseases and assessing the
istopathological studies. Laurenzana et al. [60] have reported
hat NP decreased hepatic testosterone hydroxylation and CYP2C
xpression level after oral administration, and also inhibit in vitro
YP1A1 activity in rat liver microsomes [25]. Suggesting, potential
nhibition of cyt P450s and ER functions by NP, which may  delay
xcretion from the liver.
However, there is limited information concerning the effects of
-NP based on the liver tissues damage. On the other hand, only a
ew studies reported the effects of 4-NP at low doses. Based on the
bove undertaken, there is an urgent need for quality toxicological
tudies to help understand the underlying molecular mechanism in
rder to identify biomarkers when 4-NP-induced hepatic steatosis.
-NP inducing non-alcoholic fatty liver disease (NAFLD) in rat is not
et widely studied and elucidated. We  recall that, the mechanisms
nderlying the development of this disease remain unclear; hep-
tic steatosis is considered as the manifestation of the metabolic
yndrome. In view of this, hepatic steatosis can lead to develop-
ent of obesity, insulin resistance and type 2 diabetes [36,37].
n addition, excessive weight gain affects more than 60% of dia-
etic and obese patients [35]. Moreover, below disorders of IR,
he ability of insulin to repress hormone sensitive lipase level is
educed, leading to an increased incidence of TAG lipolysis and
elease of increased FFA in the liver [33]. On the other hand, it
as been demonstrated that mitochondrial dysfunction is a key
echanism of drug-induced liver damage, that involves the par-
nt chemical or a reactive metabolite generated through cyt P450
CYP450) enzymes. 4-NP has toxicological effects that can affect
ultiple pathways, such as aril hydrocarbon receptor (AhR) and
eroxisome proliferation-activated receptor (PPAR) [10]. Previous
tudies demonstrated the involvement of PPAR isoforms  and
 in the regulation of important biological processes, including
ipidic and glucidic metabolism [54,50]. Thus, several xenobiotics
an induce mitochondrial dysfunction or reactive metabolite gen-
ration through cyt P450-mediated metabolism, also involved in
he process of -oxidation of the free fatty acids [30,23]. Theseports 2 (2015) 1423–1433
mitochondrial disturbances can lead to a variety of deleterious con-
sequences such as oxidative stress, energy shortage, accumulation
of triglycerides (steatosis), and cell death [4].
The liver lesion is commonly referred to as macrovacuolar
steatosis (MS), which is also observed in large number of obese
and diabetic patients, even in those that do not drink alcohol. MS
is relatively a benign liver lesion in the short term. Furthermore,
study has also conﬁrmed lipid droplets in mouse ﬁbroblasts (3T3-Li
cells) exposed to 4-NP [31]. Liver injury progression leads to non-
alcoholic hepatic steatosis (NASH) and apoptosis, which may  end
in hepatocellular carcinoma [13]. Bernabò et al. [6] study based on
amphibian reported large lipid droplets in liver histology and ultra-
structure after acute exposure to NPE. There is evidence that liver
apoptosis, cell proliferation, and related genes, Fas/FasL, Bax/Bcl-2,
and Caspase-8 play an important role in the genesis and devel-
opment of NASH [26]. However, currently there is a paucity of
information about the action and mechanism of 4-NP induced hep-
atic steatosis in rats. Consequently, in this original research, we
aimed to proﬁle the gene expression of liver tissues and also gain
insight into the mechanisms responsible for 4-NP-induced hepatic
steatosis after treatment with 4-NP at various doses during 30 days
period in male rats.
2. Materials and methods
2.1. Chemicals and reagents
4-Nonylphenol (NP) was purchased from DR Co. (Augsburg,
Germany, purity: 98%). Corn oil was  obtained from Sigma–Aldrich
(St. Louis, MO,  USA). Sigma Chemical Co. (St Louis, MO)  USA, Col-
lagenase, Trypsin–EDTA were obtained from GIBCO (Grand Island,
NY, USA). Sodium lauryl sulphate from SRL, Eosin stain and Hema-
toxylin stain were obtained from HiMedia (Mumbai). LDH, GOT,
GPT, -GT, CAT, GSH-Px, SOD, H2O2, and MDA  assay kit (Jiancheng
Bioengineering Ltd., Nanjing, China).
2.2. Animals and experimental design
Twenty-four male Sprague-Dawley rats (70–80 g) were
obtained from the Experimental Animal Center of Tongji Medical
College Animal Laboratory (Wuhan, China). The rats were kept
at a controlled temperature (24 ± 3 ◦C) under 12 h light–dark
cycles, humidity (50 ± 5%) environment, and fed libitum. All
protocols were approved by the institutional ethics committee
for animal research of Ministry of Health, People’s Republic of
China and received the certiﬁcate number (2011-s2456). The rats
were randomly divided into four groups, each group containing
six rats. Each group (labeled as: control group, low dose group,
middle dose group and high dose group) were fed different
doses of 4-nonylphenol A 0, 2, 10, 50 mg/kg body weight (b. wt)
respectively in corn oil every forty-eight hours by intra-peritoneal
injection for 30 days. The doses and time used for the present
study were derived from published data [56,55] and the result
of our preliminary experiment. After 30-days of treatment, the
rats were sacriﬁced. Livers were excised, blotted and weighed,
and either ﬁxed for histopathological studies, or stored at −80 ◦C
respectively.
2.3. Assessment of serum hepatic marker enzymes
Serum was  separated from blood by centrifugation at 3000 rpm
for 15 min  at 4 ◦C and kept in a freezer. The activities of serum
glutamate oxaloacetate transaminase (GOT), glutamate pyruvate
transaminase (GPT), -Glutamyl transferase (-GT) and lactate
dehydrogenase (LDH) were measured using commercially assay
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Pig. 1. Effect of 4-NP on liver biomarkers. (A) Effect of 4-NP on GOT activities (U/g
iver  of rats. (C) Effect of 4-NP on LDH activities in (U/mg of protein) the liver of ra
xpressed as mean ± SD, n = 6. The symbol represents statistical signiﬁcant (ANOVA
its (Jiancheng Bioengineering Ltd., Nanjing, China) according to
he manufacturers’ instructions.
.4. Evaluation of hepatic antioxidant enzyme and
on-enzymatic assays
.4.1. Enzyme extraction and assay
The liver was homogenized using lysis buffer (containing 1 mM
a2EDTA, 150 mM NaCl, 10 mM PMSF, 10 mM Tris, 1 mM Apro-
inin) to evaluate oxidative stress following the protocol of assay kit
Jiancheng Bioengineering Ltd., Nanjing, China). All operations were
one at 4 ◦C. Protein concentrations were determined using a BCA
it (Beyotime Biotech Inc., China) that employed serum albumin as
 standard..4.2. Estimation of liver antioxidant parameters
Measurements of catalase (CAT), glutathione peroxidase (GSH-
x), superoxide dismutase (SOD) activities, as well as hydrogentein) in the liver of rats. (B) Effect of 4-NP on GPT activities (U/g of protein) in the
) Effect of 4-NP on -GT activities (U/mg of protein) in the liver of rats. Values are
 control: *p < 0.05, **p < 0.01, ***p < 0.001.
peroxide (H2O2) and malondialdehyde (MDA) levels were per-
formed.
CAT can decompose H2O2, the absorbance at 240 nm decreas-
ing in time with advancing reaction, CAT activity was calculated
according to the rate of change in absorbance: one unit is deﬁned
as the degradation of 1 nmol H2O2 in the reaction system per mg
protein per minute.
GSH-Px activities were assayed by quantifying the rate of oxida-
tion of reduced glutathione to glutathione disulﬁde by H2O2. One
unit of GSH-Px was  deﬁned as the amount that reduced the level
of GSH by 1 M in 1 min/mg protein as determined spectrophoto-
metrically at 412 nm.
SOD activity in supernatants was  determined by measuring the
reduction of nitro blue tetrazolium (NBT) by O2− produced from the
xanthine–xanthine oxidase system. One unit of SOD  was  deﬁned as
the amount protein that inhibits the rate of NBT reduction by 50%.
Results were deﬁned as U/mg protein.
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cig. 2. Effects of 4-NP (mg/k b. wt) on oxidative stress-related genes expression of 
E)  Bcl-2, (F) Casp-9). Hepatotoxicity-related genes ((G) Fas, (H) FasL, (I) TNF-). The
f  target genes is calculated using 2−Ct. Error bars represent the standard deviati
.4.3. Reactive oxygen species
Hydrogen peroxide (H2O2) and titanium dioxide over sulfuric
cid were used to form a yellow complex, which has a characteristic
bsorption in 415 nm.  Results were deﬁned as mol/mg protein.
he level were assessed to determine the concentration of H2O2 as
 marker for reactive oxygen species (ROS)..4.4. Assessment of lipid peroxidation
The liver homogenates was assessed to determine the con-
entration of malondialdehyde (MDA) as a marker for lipidimental rat livers ((A) SOD1, (B) GPx, (C) HSP70). Apoptotic-related genes ((D) Bax,
keeping gene -actin is used as an internal positive control. The relative expression
niﬁcant difference:*p < 0.05, **p < 0.01 versus control group. n = 6.
peroxidation (LPO) and measuring thiobarbituric-acid (TBA) react-
ing substances at 532 nm.  The level of MDA  was  expressed as nmol
MDA  per milligram protein.
2.5. Histological and immunohistological examination2.5.1. Hematoxylin eosin
The liver tissues ﬁxed in Bouin’s solution were transferred to 70%
ethanol and embedded in parafﬁn. They were cut at 4 m thickness
and stained (hematoxylin and eosin (H&E)) based on standard pro-
A. Kourouma et al. / Toxicology Reports 2 (2015) 1423–1433 1427
Table  1
Grading and staging of histopathological of liver steatosis.
Grade Histological characteristics
1-Mild Steatosis: predominantly macrovesicular
Ballooning: occasionally observed
Lobular inﬂammation: scattered and mild acute inﬂammation
2-Moderate Steatosis: any degree usually mixed macrovesicular and microvesicula
Ballooning: obvious and present in centrilobular zone
Lobular inﬂammation: associated with ballooned hepatocytes
3-Severe Steatosis: typically involves >66% of lobules
Ballooning: predominantly, marked in centrilobular zone
Lobular inﬂammation: scattered acute and chronic inﬂammation
According to Brunt et al. grading and staging system for NASH [7].
Fig. 3. Hepatic histology of rats livers sections, showing cellular changes, particularly vacuoles (arrows), indicating steatosis. (D) Show several balloon cells that are much
larger  than the surrounding steatotic hepatocytes but with the same cytoplasmic characteristic as more obvious balloons, such as those seen in (B and C). Observations done
at  200× magniﬁcation (H&E). (E) Grading for steatohepatitis, three grades are summarized (steatosis, ballooning and lobular inﬂammation).
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edures. Six slides were prepared from each liver. All sections were
valuated for the degree of liver injury. All specimens were exam-
ned using a light microscope (IX-71, Olympus, Tokyo, Japan) with
igh-power magniﬁcation 200×. The extent of hepatocytes steato-
is was graded (grades 1–3) according to the Brunt et al. grading
nd staging system for NASH [7] see (Table 1). We  considered only
 & E necessary to perform the evaluation and the whole area of the
ection of each stained slides was scanned and analyzed in triplicate
or each rat.
.5.2. In situ nick-end labeling (TUNEL)
To detect apoptotic cell death, parafﬁn embedded sections were
tained by the TUNEL technique using an in situ apoptosis detec-
ion kit (Wuhan Boster Biological Technology, Ltd., Wuhan, China)
ccording to the instructions provided by the manufacturer. The
ections were deparafﬁnized with xylene, rehydrated and treated
ith 200 g/ml proteinase K for 15 min  at room temperature.
ndogenous peroxidase was inactivated by covering the sections
ith 3% H2O2 in H2O for 5 min  at room temperature. End-labeling
as obtained through catalytically adding residues of digoxygenin-
abeled 11-dUTP and dATP to the 3′-hydroxyl ends of DNA with
he enzyme TDT. The reaction buffer containing: dATP, dUTP and
DT, was performed for 60 min  at 37 ◦C in a humid atmosphere.
he digoxygenin was identiﬁed immunohistochemically with a
igoxygenin-speciﬁc peroxidase-conjugated antibody (30 min  in
 humid atmosphere at room temperature). For the color reac-
ion, metal-enhanced diaminobenzidine was used as substrate.
he sections were counterstained with hemato-xylin. Positive and
egative control sections were included in each sample. The apop-
otic cells were identiﬁed based on intense brown nuclear staining
bserved under light microscope (IX-71, Olympus, Tokyo, Japan).
he data were expressed as the average of apoptotic cell numbers
er sample. Apoptotic cells were identiﬁed by their brownish stain-
ng. The whole area of the section was scanned with the high-power
agniﬁcation (400×). The apoptotic index was then calculated as
ollows: AI = (number of apoptotic cells per section/ total number
f cells per section) x 100%.
.5.3. PCNA immunohistology
Proliferating cell nuclear antigen (PCNA) immunohistochemi-
al staining was  achieved to evaluate hepatocytes proliferation.
iver tissues were ﬁxed for 24 h in neutral buffered formalin,
rocessed routinely and embedded in wax. Immunohistochemi-
al staining was performed as previously described Kalinichenko
t al., 2003. The liver tissues were sectioned and stained utilizing
 mouse monoclonal antibody against PCNA and the SABC Staining
it (Wuhan Boster Biological Technology, Wuhan, China) accord-
ng to manufacturer’s protocol, then subjected to photomicroscopic
bservation (IX-71, Olympus, Tokyo, Japan) with high-power mag-
iﬁcation 200×. PCNA positive cells in the liver sections were
easured. The tissue sections were counted for each rat. The data
ere expressed as the average of PCNA positive cell numbers per
ample.
.6. RNA extraction and RT-PCR
Total RNA was extracted with Trizol reagents (Invitrogen, Carls-
ad, CA, USA) and the purity was determined by the Eppendorf
ioPhotometer (Ependorf, Germany), which showed an optical
ensity ratio (OD260/280) between 1.8 and 2.0. Total RNA of 2 g
as reversely transcribed to the complementary DNA by Revert
id First Strand cDNA Synthesis Kit (Fermentas, Vilnius, Lithua-
ia). The quantitative RT-PCR was performed with an ABIPRISM®
900HT Sequence Detection System (Applied Biosystems, USA)
sing Platinum® SYBR® Green qPCR SuperMix-UDG with ROX
Invitrogen, USA). The -actin was used in parallel for each run asports 2 (2015) 1423–1433
an internal control. A 10 l PCR reaction system was used, includ-
ing 2 l cDNA, 3 l primers, and 5 l Super Mix-Rox. A 4-step
experimental run protocol was  carried out and the ampliﬁcation
conditions were as follows: 50 ◦C for 2 min  (UDG incubation); 95 ◦C
for 2 min  (initial denaturation); 40 cycles of 15 s at 95 ◦C (denatu-
ration), and 1 min  at 60 ◦C (elongation). The relative expression of
target genes was calculated using 2−Ct method [38]. The primer
sequences were designed according to the cDNA sequences from
the GenBank. All primers were synthesized by the Biosia Corp
(Shanghai, China). The sequences of primers used as follows:
SOD 1 forward: 5′-ACACAAGGCTGTACCACTGC-3′;
reverse: 5′-CCACATTGCCCAGGTCTCC-3′
GPx forward: 5′-GTCCACCGTGTATGCCTTCTCC-3′;
reverse: 5′-TCTCCTGATGTCCGAACTGATTGC-3′
HSP 70 forward: 5′-ATCTCCTGGCTGGACTCTAACA-3′
reverse: 5′-CACCCATCTGTCTCCTAGATCA-3′
TNF- forward: 5′-TATGGCCCAGACCCTCACA-3′
reverse: 5′-GGAGTAGACAAGGTACAACCCATC-3′
Fas forward: 5′-ACATGGACAAGAACCATTATGCTGA-3′
reverse: 5′-CTGGTTTGCACTTGCACTTGGTA-3′
FasL forward: 5′-CATGCAGCAGCCCATGAATTAC-3′
reverse: 5′-CTCTAGGCCCACAAGATGGACAG-3′
Bcl-2 forward: 5′-TGAAGCGGTCCGGTGGATA-3′
reverse: 5′-CAGCATTTGCAGAAGTCCTGTGA-3′
Bax forward: 5′-CAGGATGCGTCCACCAAGAA-3′
reverse: 5′-CGTGTCCACGTCAGCAATCA-3′
Caspase-9 forward: 5′-TGCACTTCCTCTCAAGGCAGGACC-3′
reverse: 5′-TCCAAGGTCTCCATGTACCAGGAGC-3′
-actin forward: 5′-ACTATCGGCAATGAGCGGTTCC-3′
reverse: 5′-CTGTGTTGGCATAGAGGTCTTTACG-3′
2.7. Statistical analysis
All values expressed as (mean ± SD) were compared by one way
analysis of variance (ANOVA) followed by the Tukey–Kramer mul-
tiple comparison test. All statistical analyses were carried out using
SPSS statistical package 12.0 (SPSS Inc, Chicago, IL, USA) to deter-
mine whether the treatments of results were signiﬁcant (*p < 0.05)
or extremely signiﬁcant (**p < 0.01 and ***p < 0.001) different from
the control groups without 4-NP.
3. Results
3.1. Body and liver weight
At the beginning of the experiment, rats from different groups
showed approximately similar body weight values. The treatment
with 4-NP promoted an increase in the body weight gained when
compared to the initial weight of rats. The ﬁnal body weight (b.
wt) of animals from these groups was not statistically different
in values from untreated animals (Table 2). However, signiﬁcant
changes were observed between absolute and relative weight of
4-NP -treated groups rat liver.
3.2. Effect of treatments on liver function
The activities of GOT, GPT, LDH and -GT in blood are commonly
used to evaluate the liver function. Fig. 1 shows that the activities
of GOT, GPT, LDH (p < 0.01, p < 0.001) and -GT (p < 0.05) were sig-
niﬁcantly increased in response to 4-NP-treated group compared
to control.3.3. Effect of treatments on hepatic ROS and LPO
H2O2 and MDA  assay were routinely used to measure the extent
of lipid peroxidation. Results of Table 3 shows that the levels of
A. Kourouma et al. / Toxicology Reports 2 (2015) 1423–1433 1429
Table  2
Body weight (g) and selected absolute (g) and relative organ weight (mg/g) of male rats in control and treatment groups. Doses of 4-NP (mg/kg b.wt.).
Initial body weight (g) Final body weight (g) Liver weight
Absolute (g) Relative-to-body (mg)
Control 78.93 ± 5.96 246.63 ± 14.89 7.63 ± 1.54 30.82 ± 5.27
2  mg  75.25 ± 4.72 243.40 ± 11.76 7.94 ± 1.13 32.72 ± 5.08
10  mg 73.37 ± 6.61 260.30 ± 16.63 9.23 ± 0.78* 35.69 ± 4.20
50  mg 76.33 ± 5.97 267.91 ± 14.91 9.44 ± 0.67* 35.26 ± 2.54*
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calues are expressed as mean ± SD, n = 6. The symbol represents statistical signiﬁca
* p < 0.05.
2O2 (p < 0.01) at 50 mg/kg b. wt and MDA  (p < 0.01) at 10 and
0 mg/kg b. wt were signiﬁcantly increased in response to 4-NP-
reated group compared to control.
.4. Effect of treatments on antioxidant enzyme activity
Three antioxidant enzymes (SOD, CAT and GSH-Px) on rat
iver were determined and the results are shown in Table 3. All
he antioxidant enzyme activities were decreased signiﬁcantly
p < 0.05, p < 0.01, p < 0.001) in response to 4-NP-treated group com-
ared to control.
.5. Effect on expression of oxidative stress-related genes in liver
The levels of SOD1, GPx and HSP70 in the livers (Fig. 2A–C)
howed signiﬁcant decrease in 4-NP-treated group compared to
ontrol (p < 0.05, p < 0.01). While the level of HSP70 increased sig-
iﬁcantly (p < 0.05).
.6. Effect on expression of apoptosis-related genes in liver
The levels of Casp-9, Bax and Bcl-2 in the livers (Fig. 2DF) showed
igniﬁcant increases in 4-NP-treated group compared to control
p < 0.05). While the level of Bcl-2, which decreased signiﬁcantly
p < 0.05) (Fig. 2E).
.7. Effect on expression of hepatotoxicity-related genes in liver
The levels of Fas, FasL and TNF- in the livers (Fig. 2H-I) showed
igniﬁcant increase in 4-NP-treated group compared to control
p < 0.05, p < 0.01).
.8. Histological and immunohistological examination
.8.1. Hematoxylin eosin
Taking into consideration the alterations observed in plasma
iomarkers, oxidative stress markers, and the microscopic aspect
f the liver, no change was observed in the rats given corn oil.
hus changes refer especially to the 4-NP treated group. The accu-
ulation of lipids revealed by H&E technique (vacuoles in white)
Fig. 3B–D) was conﬁrmed by TUNEL (lipids in gray) (Fig. 4B–D).
able 3
ffect of 4-NP on liver oxidative stress and antioxidant enzyme activity in all experiment
CAT (U/mg prot) GSH-Px (U/mg prot) SOD
Control 14.045 ± 2.08 1.932 ± 0.15 14.5
2  mg  10.23 ± 1.91** 1.280 ± 0.45** 14.1
10  mg 5.833 ± 2.67*** 0.632 ± 0.39*** 12.3
50 mg 4.318 ± 2.28*** 0.471 ± 0.29*** 10.4
ffect of 4-NP on liver antioxidant enzymes and reactive oxygen species. Values are expres
ontrol.
* p < 0.05.
** p < 0.01.
*** p < 0.001.OVA) from control.
Fig. 3E. Show the liver Steatosis, ballooning and lobular inﬂamma-
tion scores according to Brunt et al. [7] The liver ballooning scores
of D group were higher than those of the B and C group at each
point. While lobular inﬂammation scores were higher than those
of the B and D group at each point.
3.8.2. In-situ nick-end labeling (TUNEL)
The TUNEL outcomes of all treatment groups are presented in
(Fig. 3). After evaluation with the light microscopic has revealed
a characteristic appearance of the normal hepatic tissue for the
control group (Fig. 4A). However, TUNEL-positive cells increased
signiﬁcantly in response to 4-NP treatment at 10 and 50 mg/kg b.
wt. In contrast, no TUNEL positive cells were seen in control group.
Thus, despite similar metabolic abnormalities, an equivalent degree
of steatosis has also been observed in 4-NP treated group. Observed
histological changes in liver tissues have shown a dose-dependent
increase (Fig. 4B–D).
3.8.3. PCNA immunohistology
The PCNA outcomes of all treatment groups are presented in
(Fig. 5). PCNA is an auxiliary protein of DNA  polymerase-delta and
higher level of its expression is correlated cell proliferation, sug-
gesting PCNA is an excellent marker of cellular proliferation. After
evaluation with the light microscopic has revealed characteristic
appearance of normal hepatic tissue of control group (Fig. 2A).
Conversely, in 4-NP-treated were markedly increased PCNA pos-
itive cell (4.64%, 8.87% and 9.07%) respectively in response to 4-NP
(2, 10 and 50 mg/kg b. wt)  in the liver tissues compared with cor-
responding control group. However, no signiﬁcant PCNA positive
cells were observed in corresponding control group. Whereas sig-
niﬁcant histological alterations in liver tissues have observed a
dose-dependent manner (Fig. 5C,D).
4. Discussion
NAFLD has become the leading cause of chronic liver injury
in developed countries. Although the exact cause of NAFLD is
still unknown, there are emerging experimental and epidemio-
logical studies proposing that some environmental contaminants
may  exert effects on promoting metabolic diseases and associated
NAFLD [17]. In this study, we sought to investigate whether admin-
al groups. Doses of 4-NP (mg/kg b.wt.).
 (U/mg prot) H2O2 (mol/mg prot) MDA  (nmol/mg prot)
02 ± 2.79 2.045 ± 0.41 1.461 ± 0.49
56 ± 2.18 2.428 ± 1.00 1.881 ± 0.55
59 ± 1.82 2.451 ± 0.28 3.013 ± 0.46**
14 ± 2.20* 3.066 ± 0.47** 3.199 ± 0.81**
sed as mean ± SD, n = 6. The symbol represents statistical signiﬁcant (ANOVA) from
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Fig. 4. Detection of apoptosis TUNEL assay in the liver tissue of rats. The presence of apoptosis after treatment with (2, 10 and 50 mg/kg/ b.wt) of 4-NP by intraperitoneal
injection for 30 days. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web  version of this article.)
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(B–D)  DNA fragmentation, characteristic of apoptosis (blacks arrows), (red arrows) in
ach  group). Observations done at 200× magniﬁcation. Apoptotic index of liver (%). T
ANOVA) from control: *p < 0.05, **p  < 0.01, ***p < 0.001.
stration of 4-NP induces steatosis in rats. Plasma GOT, GPT, LHD
nd -GT are the most sensitive markers in the diagnosis of hep-
tic injury. The results showed that the levels of GOT, GPT, LHD
nd -GT were signiﬁcantly increased in response to 4-NP-treated
roup compared to control. GOT and GPT are normally localized in
he hepatic cytoplasm, while increase in serum GOT and GPT lev-
ls by 4-NP suggests hepatic damage with their subsequent release
nto circulation. This has also been conﬁrmed by [39]. It is impor-
ant to note that, some studies have shown no changes in the serum
GOT and SGPT even at high doses of 4-NP [11,53]. This contradic-
ion could be due to the degree of toxicity depending on the dose,
ime, frequency, and strains.
ig. 5. 4-NP promotes hepatic cell proliferation in acute liver injury. Immunohistochemica
escribed. (A) PCNA staining liver sections in the rats without 4-NP administration. (B–D
ections. (E) Quantitative expression of PCNA was  signiﬁcantly higher in the liver cells at 
n  each group. Observations done at 200× magniﬁcation. PCNA+ index of liver (%). The tiss
ANOVA) from control: *p < 0.05, **p  < 0.01, ***p < 0.001.es ballooning. (E) The graph representing average number of TUNEL-positive cells in
sue sections were counted for each rat. The symbol represents statistical signiﬁcant
Through hepatic histopathological examination and serum
assays has also conﬁrmed, microvesicular steatosis was observed in
4-NP-treated group. As illustrated in result section the hepatocytes
ballooning is the most characteristic feature of steatosis-hepatitis;
which is typically associated with formation of Mallory’s hyaline.
The severity of steatosis appears to be important in determining the
extent of apoptosis. For this purpose, we  carried out the grading and
staging system for NASH according to [7].
To investigate the mechanism of intraperitoneal exposure to 4-
NP, which lead to increased susceptibility of the development of
NAFLD in male rats, a massively parallel deep-sequencing was  car-
ried out to identify the genome-wide proﬁles of the liver tissues
after treatment. We  observed that the expression of Fas/FasL, TNF-
l staining for proliferating cell nuclear antigen (PCNA) was carried out as previously
) Low middle and high dose respectively, arrows indicate PCNA+ cells in the liver
dose 10 and 50 mg/kg b. wt. The graph representing average number of PCNA+ cells
ue sections were counted for each rat. The symbol represents statistical signiﬁcant
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 and Casp-9 mRNA activation in 4-NP-treated group increased
ith hepatic steatosis. The expression level increased gradually
howing a positive correlation with NASH levels and the liver
poptosis percentage, suggesting that the incidence and develop-
ent of up regulation of Fas/FasL, TNF- and Casp-9 activation at
ose 10 and 50 mg/kg b.wt. respectively thus indicating that 4-NP
nduces extrinsic apoptosis; as echoed by Jubendradass et al. [19].
n addition to this, TNF- acts as a simulator of NADPH-dependent
2O2 generation [22]. Increase of TNF- and lipid peroxidation
ere observed at 4-NP-treated group and particularly signiﬁcant
t dose 50 mg/kg b.wt. This is the most important factor causing
nd maintaining insulin resistance [48], and closely related to the
evelopment of NAFLD and other metabolic disorders [16]. Despite
he existing correlation between steatosis and insulin resistance,
elow disorders of IR, the ability of insulin to repress hormone sen-
itive lipase level is reduced, leading to an increased incidence of
AG lipolysis and release of increased FFA into the liver [47]. This
rocess is an independent hazard factor for NAFLD severity.
Several genes associated with liver function were signiﬁcantly
hanged. Alterations in the expression of Bcl-2 and Bax genes indi-
ate the involvement of an intrinsic apoptotic mechanism. Whereas
aspases point towards the role of an alternative pathway [18].
n our present ﬁndings, dysregulation of Casp-9 and Bax mRNA
apoptotic), and also Bcl-2 expression (pro-survival) results in the
elease of cyt C; cyt C, a pro-apoptotic factor released from outer
itochondrial membrane to cyt, form a complex with Apaf-1 and
rocaspase-9, resulting in activation of Casp-9. Activated Casp-9
ctivates the effector Casp-3 leading to degradation of DNA and
ellular constituents [1]. Nevertheless, in response to DNA dam-
ge, protein p53 will be activated [34]. This protein, directly or
ndirectly, modulates the expression of some proteins that con-
rol mitochondrial membrane permeability (MMP), resulting in the
elease of cyt C [14]. Mitochondrial cyt C together with the Apaf-1
apoptotic protease activating factor 1) and dATP (nucleotide pre-
ursors) form apoptosome that activates Casp-9 (initiator caspase).
urthermore, this initiator caspase begin the apoptosis process
hrough the activation of executor caspase [45]. DNA fragmenta-
ion was conﬁrmed by TUNEL assay. These observations further
alidate the theory that mitochondria dysfunction induced by 4-
P can be a cause, effect or concurrent feature in the development
f NAFLD. This assertion has been conﬁrmed by [40]. In addition,
itochondrial dysfunction involved in the process of -oxidation
f FFA, then impairs fat homeostasis in the liver, but also leads to
n overproduction of oxidative stress, resulting in the generation of
OS that trigger LPO, cytokine overproduction and cell death [46].
n the other hand, ROS produced mitochondria FAO in liver cells
ill further simultaneously release cyt C, which eventually triggers
epatic apoptosis through the mitochondria-dependent pathways
27].
A wide range of injurious stresses relevant to liver disease lead
o MMP  pore opening [29]. It can therefore be proved that, ROS
verproduction or antioxidant reductions are the direct causes of
xidative stress. Previous research have reported that endocrine
isruptor like bisphenol A exhibit adverse effects at very low doses.
owever, only a few studies have reported the effects of NP at low
oses. Administration of NP at a dose level of 50 g/kg b.wt/day
or 30 days has been shown to increase oxidative stress in blood
f adult male rats. Many factors may  cause the production of
OS, including 4-NP exposure. The change in antioxidant enzyme
ctivities is relevant to the ability of the liver to ﬁght against oxida-
ive stress during 4-NP exposure. This study showed that SOD,
AT, GSH-Px levels were signiﬁcantly decreased in the liver after
he treatment of 4-NP compared with the control group. In order
o support this hypothesis we have considered in our work that
nhance of H2O2 and MDA  as marker for LPO and as indicator
f oxidative liver injury [9]. All these indicated that 4-NP pro-ports 2 (2015) 1423–1433 1431
mote antioxidant activity to induce liver damage. SOD presents
in three isoforms, copper-zinc-containing superoxide dismutase
(Cu–Zn–SOD, SOD1), manganese containing superoxide dismu-
tase (Mn–Zn–SOD, SOD2) and extracellular superoxide dismutase
(Cu–Zn–SOD, SOD3). The SOD1 isoenzyme is the most abundant
one in the cytoplasm [5]. Reduction of SOD1 activity in 4-NP-treated
group in this study might be due to the enhanced production of
superoxide radical anions. GPx is an antioxidant enzyme, which
modiﬁes the peroxide anion to a non-toxic hydroxyl compound in
order to protect the membrane structure and function. The decrease
of these antioxidants enzymes may  be suggestive for the process
of LPO. These processes are situated to be responsible for initiat-
ing necroinﬂammation, and ROS, which are generated during FFA
metabolism in microsomes, peroxisomes and mitochondria. These
cytotoxic ROS and LPO products are able to disperse within the
extracellular interspaces worrying HSC and Kupffer cells [47], that
may  play substantial roles in the evolution of chronic liver inﬂam-
mation and ﬁbrosis development [43].
HSP70 is one of the most abundantly induced proteins under
a variety of stress conditions and the extensive oxidative stress
marker at present [51], and is often correlated with the emphasis
on the process of apoptosis [3] by inhibiting the formation of apop-
tosome [8]. This can also suppress the apoptotic process through
other pathway by blocking the activation of stress induced kinases
such as apoptosis signal-regulating kinase 1 (ASK1) and c-Jun N-
terminal kinases (JNK) [15]. The increase in the levels of HSP70
mRNA may  be due to the presence of higher event of OS and cell
damage. This can be conﬁrmed by the increase in the number of
positive PCNA cell staining of hepatocytes, which is the central
molecule responsible for taking decisions of life and death of the
cell. Its increase is associated with cell death [28]. This observa-
tion may  be due to ROS induction and disruption of the balance
between ROS and antioxidant defense system. This data concurs
with previous ﬁndings [21]. On the other hand, Excess FA accumu-
lation in hepatocytes induces oxidative stress in mitochondria but
also microsomes and peroxisomes. This study also demonstrated
increase in body weight gain and absolute and relative liver weight
of 4-NP treatment rats. The augmentation of the size of the liver is
commonly observed in patients with several Hepatomegaly [2] and
also might be a crucial mechanism for its developmental toxicity
in male rat hepatocytes.
In addition, FAO and oxidative stress occurs in the mitochon-
dria, and are considered to play a critical role in the pathogenesis
of NALFD [58]. Hepatocytes apoptosis is commonly manifested in
several liver diseases. In previous years, large progress has been
made with regard to elucidate the role of apoptosis in the occur-
rence and development of NAFLD (e.g., [44,52] and its subsequent
progression to NASH, liver ﬁbrosis, cirrhosis and liver cancer.
5. Conclusion
Intraperitoneal administration of 4-NP promotes an increase
in the susceptibility to hepatic steatosis, which is associated with
apoptosis, positive proliferation of hepatocytes and subsequent
oxidative stress prior to the development of NALD. However, this
present study may  merit discussion and it would be important
to research new mechanism-speciﬁc biomarkers of hepatocellular
injury, which would be a suitable opportunity to assess the impacts
of variations in 4-NP concentrations on liver function and dam-
ages as well as protein measurements by immunoblot analysis to
support this conclusion. However, our present research demon-
strated the ﬁrst evidence that 4-NP promote hepatic steatosis in
male rats, disturbing hepatotoxicity-related genes expression in
liver; as well as up-regulation of the expression of Fas/FasL ratio
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